SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Amneal Pharmaceuticals Q1 EPS $0.20 Beats $0.09 Estimate, Sales $498.533M Beat $444.230M Estimate

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.200 per share which beat the analyst consensus estimate of $0.090 by 122.22 percent. This is a 42.86 percent increase over earnings of $0.140 per share

Benzinga · 05/11/2020 10:38

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.200 per share which beat the analyst consensus estimate of $0.090 by 122.22 percent. This is a 42.86 percent increase over earnings of $0.140 per share from the same period last year. The company reported quarterly sales of $498.533 million which beat the analyst consensus estimate of $444.230 million by 12.22 percent. This is a 11.75 percent increase over sales of $446.120 million the same period last year.